Antioxidant system in dermatology;Dermatolojide antioksidan sistem

Turk Dermatoloji Dergisi

Volumn 3, Issue 2, 2009, Pages 32-39

  Karaca, Şemsettin ^a   Güder, Hüsna ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Antioxidants; Oxidative stress; Skin disorders

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CYCLIC AMP; CYCLIC GMP; DNA; FERROUS ION; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; REACTIVE OXYGEN METABOLITE; RETINOL; SUPEROXIDE; ZINC CHLORIDE;

ACNE VULGARIS; ATOPIC DERMATITIS; BEHCET DISEASE; CATALYSIS; DERMATOLOGY; ENZYME ACTIVATION; FENTON REACTION; IN VITRO STUDY; IRRITANT DERMATITIS; KERATINIZATION; LIPID PEROXIDATION; MUTATION; NUCLEOTIDE SEQUENCE; PSORIASIS; PUVA; REVIEW; SKIN DISEASE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; VITILIGO;

EID: 77953430388     PISSN: 13077635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (105)

1. Pinnell SR. Cutaneous photodamage, oxidative stress, and topical antioxidant protection. J Am Acad Dermatol 2003;48:1-19.
2. Halliwell B, Cross CE. Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect 1994;102 (Suppl 10): 5-12.
3. Powers SK, Hamilton K. Antioxidants and exercise. Clin Sports Med 1999; 18: 525-536
4. Miyachi Y. Biochemistry of the physiopathologic and clinical aspects of free radicals in skin diseases. Nippon Rinsho1988; 46: 2252-2256
5. Parola M, Bellomo G, Robino G, et al. 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antioxid Redox Signal 1999;1: 255-284. (Pubitemid 129622798)
6. Nachbar F and Korting HC. The role of vitamin E in normal and damaged skin. J Mol Med 1995; 73: 7-17.
7. Trouba KJ, Hamadeh HK, Amin RP, et al. Oxidative Stress and Its Role in Skin Disease. Antioxid Redox Signal 2002; 4(4): 665-673 (Pubitemid 35001451)
8. Burton G and Ingold K. Mechanisms of Antioxidant Action: Preventive and Chain-Breaking Antioxidants. Boca Raton, FL: CRC Press, 1989, pp. 29-43.
9. Becker BF, Reinholz N, Leipert B, et al. Role of uric acid as an endogenous radical scavenger and antioxidant. Chest 1991; 100 (3 Suppl): 176S-181S.
10. Rice-Evans CA, Burdon RH. Free Radical Damage and its Control. Amsterdam: Elsevier Science B.V., 1994, pp. 113-114
11. Hoppe U, Bergemanna J, Diembecka W, et al. Coenzyme Q10, a cutaneous antioxidant and energizer. BioFactors 1999; 9: 371-378 (Pubitemid 29289021)
12. Tyrrell RM. The molecular and cellular pathology of solar ultraviolet radiation. Mol Aspects Med 1994;15:1-77. (Pubitemid 24164703)
13. Fuchs J. Oxidative Injury in Dermatopathology. Berlin, Heidelberg: Springer-Verlag, 1992, pp. 48-57.
14. Arner ES, Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 2000; 267: 6102-6109
15. Schallreuter KU, Wood JM. Thioredoxin reductase-its role in epidermal redox status. J Photochem Photobiol B 2001; 64: 179-184
16. Sato M, Bremner I. Oxygen free radicals and metallothionein. Free Radic Biol Med 1993; 14: 325-337
17. Liochev SI, Fridovich I. The role of O2 in the production of HO: in vitro and in vivo. Free Radic Biol Med 1994; 16: 29-33.
18. Tsuji Y, Ayaki H, Whitman SP, et al. Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol Cell Biol 2000; 20: 5818-5827 (Pubitemid 30613031)
19. Kensler TW, Trush MA. Role of oxygen radicals in tumor promotion. Environ Mutagen 1984; 6: 593-616.
20. Renzing J, Hansen S, Lane DP. Oxidative stress is involved in the UV activation of p53. J Cell Sci 1996; 109: 1105-1112 (Pubitemid 26168262)
21. Maxwell SA, Roth JA. Posttranslational regulation of p53 tumor suppressor protein function. Crit Rev Oncog 1994; 5: 23-57. (Pubitemid 2125991)
22. Ueda M, Matsunaga T, Bito T, et al. Higher cyclobutane pyrimidine dimer and (6-4) photoproduct yields in epidermis of normal humans with increased sensitivity to ultraviolet B radiation. Photodermatol Photoimmunol Photomed 1996;12: 22-26 (Pubitemid 26298021)
23. Muramatsu T, Kobayashi N, Tada H, et al. Induction and repair of UVB induced cyclobutane pyrimidine dimers and (6-4) photoproducts in organ-cultured normal human skin. Arch Dermatol Res 1992;284: 232-237
24. Slaga TJ. Inhibition of the induction of cancer by antioxidants. Adv Exp Med Biol 1995;369:167-174
25. Ichihashi M, Ahmed NU, Budiyanto A, et al. Preventive effect of antioxidant on ultraviolet-induced skin cancer in mice. J Dermatol Sci 2000;23 (Suppl 1):S45-S50, (Pubitemid 30183890)
26. David R. Bickers, Athar M. Oxidative Stress in the Pathogenesis of Skin Disease. Journal of Investigative Dermatology 2006;126:2565-2575 (Pubitemid 44764040)
27. Stewart MS, Cameron GS, Pence BC. Antioxidant nutrients protect against UVB-induced oxidative damage to DNA of mouse keratinocytes in culture. J Invest Dermatol 1996;106:1086-1089
28. Nakamura Y, Colburn NH, Gindhart TD. Role of reactive oxygen in tumor promotion: implication of superoxide anion in promotion of neoplastic transformation in JB-6 cells by TPA. Carcinogenesis 1985;6:229-233 (Pubitemid 15172799)
29. Kripke ML, Fisher MS. Immunologic parameters of ultraviolet carcinogenesis. J Natl Cancer Inst 1976;57:211-215
30. Vink AA, Strickland FM, Bucana C, et al. Localization of DNA damage and its role in altered antigen-presenting cell function in ultraviolet-irradiated mice. J Exp Med 1996;183:1491-1500 (Pubitemid 26134292)
31. Steenvoorden DP, Beijersbergen van Henegouwen G. Protection against UV-induced systemic immunosuppression in mice by a single topical application of the antioxidant vitamins C and E. Int J Radiat Biol 1999;75:747-755
32. Fuchs J and Packer L. Antioxidant protection from solarsimulated radiation-induced suppression of contact hypersensitivity to the recall antigen nickel sulfate in human skin. Free Radic Biol Med 1999;27:422-427 (Pubitemid 29395436)
33. Steenvoorden DP, Beijersbergen van Henegouwen G. Glutathione ethylester protects against local and systemic suppression of contact hypersensitivity induced by ultraviolet B radiation in mice. Radiat Res 1998;150:292-297
34. Mathews-Roth MM, Pathak MA, Fitzpatrick TB et al. Beta-carotene as a protective agent in erythropoietic protoporphyria. New Eng J Med 1970;282:1231-1234
35. Mathews-Roth MM, Pathak MA, Fitzpatrick TB et al. b-carotene as an oral photoprotective agent in erythropoietic protoporphyria. JAMA 1974;228:1004-1008
36. Hindmarsh JT. The porphyrias: recent advances. Clin Chem 1986; 32: 1255-1263
37. Giles A, Wamer W, Kornhauser A. In vivo protective effect of B-carotene against psoralen phototoxicity. Photochem Photobiol 1985;41:661-666
38. Wolf C, Steiner A, Honigsmann H. Do oral carotenoids protect human skin against ultraviolet erythema, psoralen phototoxicity, and ultraviolet-induced DNA damage? J Invest Dermatol 1988;90:55-57
39. Suhonen R, Plosila M. The effect of beta-carotene in combination with canthaxin, Ro 8-8427 (PhenoroR), in treatment of polymorphous light eruptions. Dermatologica 1981;163:172-176
40. Corbett MF, Hawk JL, Herxheimer A, et al. Controlled therapeutic trials in polymorphous light eruption. Br J Dermatol 1982;107:571-581
41. Jansen CT. Oral carotenoid treatment in polymorphous light eruption. A crossover comparison with oxychloroquine and placebo. Photodermatology 1985;2:166-169
42. Ahmed RS, Suke SG, Seth V, et al. Impact of oral vitamin E supplementation on oxidative stress & lipid peroxidation in patients with polymorphous light eruption. Indian J Med Res 2006;123(6):781-787 (Pubitemid 44269945)
43. Record IR, Jannes M, Dreosti IE. Protection by zinc against UVAand UVB-induced cellular and genomic damage in vivo and in vitro. Biol Trace Elem Res 1996;53:19-25. (Pubitemid 26271882)
44. Reeve VE, Nishimura N, Bosnic M, et al. Dietary zinc, photoimmunosuppression and metallothionein (MT). In: Klaassen C, editor. Metallothionein IV. Basel, Switzerland: Birkhauser Verlag; 1999. p. 445-449
45. Fuchs J, Kern H. Modulation of UV-light-induced skin inflammation by D-α-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation. Free Radic Biol Med 1998;25:1006-1012 (Pubitemid 28558326)
46. Lin J, Selim A, Shea C, et al. UV photoprotection by combination topical antioxidants vitamin C and E. J Am Acad Dermatol 2003;48(6):866-874 (Pubitemid 36706218)
47. Wartanowicz M, Panczenko-Kresowska B, Ziemlanski S, et al. The effect of alpha-tocopherol and ascorbic acid on the serum lipid peroxide level in elderly people. Ann Nutr Metab 1984;28:186-191 (Pubitemid 14125833)
48. Tolonen M, Sarna S, Halme M, et al. Anti-oxidant supplementation decreases TBA reactants in serum of elderly. Biol Trace Elem Res 1988;17:221-228 (Pubitemid 18267829)
49. Tada-Oikawa S, Oikawa S, Kawanishi S. Role of ultraviolet A-induced oxidative DNA damage in apoptosis via loss of mitochondrial membrane potential and caspase-3 activation, Biochemical Biophysical Research Communications 1998;247(3):693-696 (Pubitemid 28418453)
50. Lehmann J, Pollet D, Peker S, et al. Kinetics of DNA strand breaks and protection by antioxidants in UVA- or UVBirradiated HaCaT keratinocytes using the single cell gel electrophoresis assay. Mutation Research 1998;407:97-108. (Pubitemid 28241551)
51. Scharffetter K, Wlaschek M, Hogg A, et al. UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo, Archives of Dermatological Research 1991;283(8):506-511
52. Hara M, Kikuchi K, Watanabe M, et al. Senile xerosis: functional, morphological, and biochemical studies. Journal of Geriatric Dermatology 1993;1:112-120
53. Bisset DL, Hillebrand GG, Hannon DP. The hairless mouse as a model of skin photoaging: its use to evaluate photoprotective materials. Photodermatology 1989;6:228-233
54. Trevithick JR, Xiong H, Lee S. Topical tocopherol acetate reduces post-UVB, sunburn-associated erythema, edema, and skin sensitivity in hairless mice. Arch Biochem Biophys 1992;296:575-582
55. Kang S, Chung JH, Lee JH, et al. Topical N-Acetyl Cysteine and Genistein Prevent Ultraviolet-Light-Induced Signaling That Leads to Photoaging in Human Skin in vivo. J Invest Dermatol 2003;120:835-841 (Pubitemid 36529087)
56. Das UN, Vijaykumar K, Madhavi N, et al. Psoriasis: current concepts and new approaches to therapy. Med Hypotheses 1992;38:56-62.
57. Raynaud F, Brion DE, Gerbaud P. Oxidative modulation of cyclic AMP-dependent protein kinase in human fibroblasts: Possible role in psoriasis. Free Radic Biol Med 1997;22:623-632 (Pubitemid 27043399)
58. Turner CP, Toye AM, Jones OTG. Keratinocyte superoxide generation. Free Radic Biol Med 1998; 24:401-407
59. Popov I, Lewin G. A deficient function of the antioxidative system of the organism as an aetiopathogenetic factor in psoriasis. Med Hypotheses 1991;35:229-236
60. Yildirim M, Inaloz HS, Baysal V, et al. The role of oxidants and antioxidants in psoriasis. JEADV 2003;17:34-36
61. Polkanov VS, Bochkarev IM, Shmeleva LT, et al. Lipid peroxidation and the blood antioxidant activity in psoriasis. Vestn Dermatol Venereol 1987;7:42-46
62. Ivanova IP, Mareeva TE. Disorders of lipid peroxidation and of lysosomal hydrolase activity and their correction in psoriasis patients. Vestn Dermatol Venereol 1987;4:26-31.
63. Miyachi Y, Niwa Y. Effects of psoriatic sera on the generation of oxygen intermediates by normal polymorphonuclear leucocytes. Arch Dermatol Res 1983;275:23-26 (Pubitemid 13152278)
64. Savitha G, Salimath BP. Cross-talk between protein kinase C and protein kinase A down-regulates the respiratory burst in polymorphonuclear leukocytes. Cell Signal 1993;5:107-117 (Pubitemid 23101417)
65. Raynaud F, Evain-Brion D, Gerbaud P, et al. Oxidative modulation of cyclic AMP-dependent protein kinase in human fibroblasts: possible role in psoriasis. Free Radic Biol Med 1997;22:623-632 (Pubitemid 27043399)
66. Brion DE, Raynaud F, Plet A, et al. Deficiency of cyclic AMP-dependent protein kinases in human psoriasis. Proc Natl Acad Sci U S A 1986;83:5272-5276 (Pubitemid 16051357)
67. Pastan IH, Johnson GS, Anderson WB. Role of cyclic nucleotides in growth control. Annu Rev Biochem 1975;44:491-522.
68. Shilov VN, Sergienko VI. Oxidative stress in keratinocytes as an etiopathogenetic factor of psoriasis. Bull Exp Biol Med 2000;129:364-369
69. Mader K, Bacic G, Swartz HM. In vivo detection of anthralin- derived free radicals in the skin of hairless mice by lowfrequency electron paramagnetic resonance spectroscopy. J Invest Dermatol 1995;104:514-517
70. Lange RW, Hayden PJ, Chignell CF. Anthralin stimulates keratinocyte-derived proinflammatory cytokines via generation of reactive oxygen species. Inflamm Res 1998;47:174-181
71. Mrowietz U, Falsafi M, Schroder JM, et al. Inhibition of human monocyte functions by anthralin. Br J Dermatol 1992;127:382-386
72. Potapenko AY, Kyagova AA. The application of antioxidants in investigations and optimization of photochemotherapy. Membr Cell Biol 1998;12:269-278 (Pubitemid 29015689)
73. Lange RW, Germolec DR, Foley JF, et al. Antioxidants attenuate anthralin-induced skin inflammation in BALB/c mice: role of specific proinflammatory cytokines. J Leukoc Biol 1998;64: 170-176
74. Hann SK. Autocytotoxic hypothesis for the destruction of melanocytes as the cause of vitiligo. In: Hann SK, Nordlund JJ (eds) Blackwell, Oxford;2000, pp 137-141
75. Schallreuter KU, Wood JM, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991;97:1081-1085
76. Maresca V, Roccella M, Roccella F, et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 1997;109:310-313 (Pubitemid 27394643)
77. Chakraborty DP, Roy S, Chakraborty AK. Vitiligo, psoralen, and melanogenesis: some observations and understanding. Pigment Cell Res 1996;141:301-303 (Pubitemid 126482941)
78. Agrawal D, Shajil EM, Marfatia YS, et al. Study on the antioxidant status of vitiligo patients of diVerent age groups in Borada. Pigment Cell Res 2004;17:289-294 (Pubitemid 38724560)
79. Picardo M, Passi S, Morrone A, et al. Antioxidant status in the blood of patients with active vitiligo. Pigment Cell Res 1994;2:110-115
80. Courtney B, Casp Jin-Xiong S, Wayne T, et al. Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res 2002;15:62-66
81. Yildirim M, Baysal V, Inaloz HS, et al. The role of oxidants and antioxidants in generalized vitiligo. J Dermatol 2003;30:104-108 (Pubitemid 36368109)
82. Ines D, Sonia B, Riadh BM, Amel EG, et al. A comparative study of oxidant-antioxidant status in stable and active vitiligo patients. Arch Dermatol Res 2006;298:147-152 (Pubitemid 44325626)
83. Jimbow K, Chen H, Park JS, et al. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol 2001;144:55-65. (Pubitemid 32154593)
84. S Briganti, M Picardo. Antioxidant activity, lipid peroxidation and skin diseases. What's new. JEADV 2003;17:663-669 (Pubitemid 37428088)
85. Akyol M, Celik VK, Ozcelik S, et al. The effects of vitamin E on the skin lipid peroxidation and the clinical improvement in vitiligo patients treated with PUVA. Eur J Dermatol 2002;12:24-26 (Pubitemid 34131134)
86. Schallreuter KU, Moore J, Behrens-Williams S, et al. In vitro and in vivo identification of pseudocatalase activity in Dead Sea water using Fourier transform Raman spectroscopy. J Raman Spectrosc 2002;33:586-592
87. Schallreuter KU, Wood JM, Lemke KR, et al. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology 1995;190:223-229
88. Schallreuter KU, Moore J, Behrens-Williams S, et al.. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PCKUS). Int J Dermatol 2002;41:482-487 (Pubitemid 35021486)
89. Bengtsson A, Lundberg M, Avila-Carino J, et al. Thiols decrease cytokine levels and down-regulate the expression of CD30 on human allergen-specific T helper (Th) 0 and TH2 cells. Clin Exp Immunol 2001;123:350-360 (Pubitemid 32289951)
90. Tsoureli-Nikita E, Hercogova J, Lotti T, et al. Evaluation of dietary intake of vitamin E in the treatment of atopic dermatitis: a study of the clinical course and evaluation of the immunoglobulin E serum levels. Int J Dermatol 2002;41:146-150 (Pubitemid 34601108)
91. Thiele JJ, Weber SU, Packer L. Sebaceous gland secretion is a major physiologic route of vitamin E delivery to skin. J Invest Dermatol 1999;113:1006-1010 (Pubitemid 30013345)
92. Berardesca E, Distante E, Vignoli GP, et al. Alpha hydroxyacids modulate stratum corneum barrier function. Br J Dermatol 1997;137:934-938 (Pubitemid 28011134)
93. Örem A, Efe H, Deǧer O, et al. Relationship between lipid peroxidation and disease activity in patients with Behçet's disease. J Dermatol Sci 1997;16:11-16 (Pubitemid 28004768)
94. Chambers JC, Haskard DO, Kooner JS. Vascular endothelial function and oxidative stress mechanisms in patients with Behcet's syndrome. J Am Coll Cardiol 2001;37:517-520 (Pubitemid 32147263)
95. Weiss SJ. Tissue destruction by neutrophils. N Eng J Med 1989;320: 365-376
96. Kökçam I, Naziroǧlu M. Effects of vitamin E supplementation on blood antioxidants levels in patients with Behçet's disease. Clinical Biochemistry 2002;35:633-639 (Pubitemid 36009331)
97. Köse K, Doǧan P, Aşçioǧlu M, et al. In vitro antioxidant effect of Ginkgo biloba extract (EGb 761) on lipoperoxidation induced by hydrogen peroxide in erythrocytes of Behçet's patients. Jpn J pharmacol 1997;75(3):253-258
98. Pehr K, Forsey RR. Why don't we use vitamin E in dermatology? Can Med Assoc J 1993;149:1247-1253
99. Baumann LS, Spencer J. The effects of topical vitamin E on the cosmetic appearance of scars. Dermatol Surg 1999;25:311-315 (Pubitemid 29191320)
100. Jenkins M, Alexander JW, MacMillan BG, et al. Failure of topical steroids and vitamin E to reduce postoperative scar formation following reconstructive surgery. J Burn Care Rehabil 1986;7:309-312 (Pubitemid 16010121)
101. Galeano M, Torre V, Deodato B, et al. Raxofelast, a hydrophilic vitamin E-like antioxidant, stimulates wound healing in genetically diabetic mice. Surgery 2001;129:467-477 (Pubitemid 32289898)
102. Altavilla D, Saitta A, Cucinotta D, et al. Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. Diabetes 2001;50:667-674 (Pubitemid 32195234)
103. Hayakawa R, Ueda H, Nozaki T, et al. Effects of combination treatment with vitamins E and C on chloasma and pigmented contact dermatitis. A double blind controlled clinical trial. Acta Vitaminol Enzymol 1981;3:31-38
104. Karaca S, Kulac M, Uz E, et al. Erythrocyte oxidant/antioxidant status in essential hyperhidrosis. Molecular and Cellular Biochemistry 2006;290:131-135 (Pubitemid 44473243)
105. Karaca S, Kulac M, Uz E , et al. Is nitric oxide involved in the pathophysiology of essential hyperhidrosis? Int J Dermatol 2007;46:1027-1030